Phytase Market (Type: Granular, Powder, Liquid, Thermostable; Application: Food, Feed, Pharmaceuticals) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2025

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 149

Introduction

Phytase (myo-inositol hexakisphosphate phosphohydrolase) is every type of phosphatase enzyme that catalyzes the hydrolysis of phytic acid. It is an enzyme which breaks down phytate and enhances calcium (Ca), zinc (Zn), sodium (Na), magnesium (Mg) and amino acid availability and digestibility in broilers and pigs. Phytases fall into two main categories:

  • Fungal phytases, from Aspergillus or Peniophera species
  • Bacterial phytases, from Escherichia coli

By type, powder and granular type collectively accounted for more than 60% share of the global market. These two types are also projected to be the fastest growing segment over the next six years. Liquid is another widely used type. It is projected to grow at a CAGR of 5.8% over the next six years in terms of revenue. Huvepharma has developed a new form for enzyme application in the feed mill: water soluble enzymes which are distorted into fluid enzymes for PPLA (Post Pellet Liquid Application), on site at the feed mill. The NSP enzyme Hostazym X and the phytases Hostazym P and OptiPhos are both available as water soluble powders (WSP). Production takes place by a unique method, as the enzymes have to be extremely concentrated and instantly water soluble in icy water. Large product availability at competitive prices and increasing demand in areas where product can be obtained in liquid form easily will open new avenues for liquid animal feed phytase market growth.

The market research study on “Phytase Market (Type: Granular, Liquid, Powder, Thermostable; Application: Pharmaceuticals, Food, Feed) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2025” offers a detailed insights on the global phytase market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report provides insights on global phytase market, its type, application, and major geographic regions. The report covers basic development policies and layouts of technology development processes. Secondly, the report covers global phytase market size and volume, and segment markets by type, application, and geography along with the information on companies operating in the market. The phytase market analysis is provided for major regional markets including North America, Europe, Asia Pacific, Latin America, Middle East & Africa followed by major countries. For each region, the market size and volume for different segments has been covered under the scope of report. The major players profiled in the report include BASF, DuPont, DSM, AB Enzymes, Guangdong VTR Bio-Tech Co., Ltd, Beijing Smistyle, Jinan Tiantianxiang (TTX), and others.

The global phytase market is segmented as below:

Market Segmentation

Market By Type

  • Granular
  • Powder
  • Liquid
  • Thermostable

Market By Application

  • Food
  • Feed
  • Pharmaceuticals

Market By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa


Related Reports

Meningococcal Vaccines Market (By Type: Combination Vaccines [MenHibrix, Menitorix], Conjugate Vaccines [Menactra, MenAfriVac, Meningitec, Menjugate, Menveo, NeisVac-C, Nimenrix, NmVac4-DT], Polysaccharide [Mencevax, Menomune, NmVac4, Others], Men B Vaccines [Bexsero, Trumenba], Others; By End User: Retail Pharmacies, Hospital Pharmacies, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction: Meningococcal vaccines are utilized to treat meningitis brought about by bacterium N. meningitidis. Beforehand there were no careful steps accessible to maintain a strategic distance from meningitis. Anti-infection agents alongside supplement supplements were utilized to treat this ailment after the disease was affirmed. In any case, with the approach of the meningoco

Real-time PCR (qPCR) and Digital PCR (dPCR) Market (By Technology: Digital, Quantitative; By Product: Instruments, Reagents and Consumables, Software & Services; By Application: Research [Forensic and Others], Clinical [Pathogen Testing, Oncology Testing, Blood Screening, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Real-time PCR (qPCR) & Digital PCR (dPCR) market is expected to grow at noteworthy CAGR around 8.1 % throughout the forecast period and reach around US$ 4.2 billion by 2026. In order to amplify or make more copies of the deoxyribonucleic acid (DNA) sequence

Nebulizer Market (By Type: Mesh, Pneumatic [Portable, Standalone], Ultrasonic [Portable, Standalone) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Nebulizer market is expected to grow at noteworthy CAGR around 6.2 % throughout the forecast period and reach around US$ 1.4 billion by 2026. Nebulizer is a medical device that converts the medicine into a nebula and directly into the pulmonary system. Nebuliza

Motion Preservation Devices Market (By Product: Total Disc Replacement Devices, Prosthetic Nucleus Replacement Devices, Posterior Dynamic Devices, Facet Replacement Devices; By Surgery: Open Spine Surgery, Minimally Invasive Spine Surgery; By End Use: Hospitals, Ambulatory Surgical Centers, Orthopedic Centers and Clinics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Motion Preservation Devices market is expected to grow at noteworthy CAGR around 10.5 % throughout the forecast period and reach around US$ 1.5 billion by 2026. In spinal disorders, movement preservation devices are used. Motion conservation devices are used to

Hemoglobinopathy Market (By Type: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb Variants Diseases; By Therapy: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb Variants Diseases; By Diagnosis: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb variants diseases) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Hemoglobinopathy market is expected to grow at noteworthy CAGR around 10 % throughout the forecast period and reach around US$ 12 billion by 2026. Hemoglobinopathy is a genetic disorder that causes structural abnormalities in hemoglobin molecules. Hemoglobinopa

Cart Summary